Anecortave Acetate Sterile Suspension, 60 mg/mL

DRUG7 trials

Sponsors

Alcon Research

Conditions

AMDEye DiseasesMacular DegenerationOcular HypertensionOpen-Angle GlaucomaOpen-angle GlaucomaOular Hypertension

Phase 2

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

CompletedNCT00315640

Alcon ResearchEye Diseases

Start: 2005-12-31End: 2009-07-31Updated: 2012-11-28

Anecortave Acetate in Patients With Open-angle Glaucoma

CompletedNCT00320203

Alcon ResearchOpen-angle Glaucoma

Start: 2006-03-31End: 2008-01-31Updated: 2012-11-28

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00691717

Alcon ResearchOpen-angle Glaucoma, Oular Hypertension

Start: 2008-06-30End: 2009-09-30Updated: 2012-11-28

A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

TerminatedNCT00788541

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2008-12-31End: 2009-09-30Updated: 2012-11-30

Phase 3

Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)

CompletedNCT00299507

Alcon ResearchMacular Degeneration

Start: 2005-03-31End: 2008-04-30Updated: 2012-11-28

Anecortave Acetate Risk Reduction Trial (AART)

TerminatedNCT00332657

Alcon ResearchAMD

Start: 2006-09-30End: 2008-12-31Updated: 2012-11-28

Anecortave Acetate Risk-Reduction Trial (AART)

TerminatedNCT00333216

Alcon ResearchAMD

Start: 2005-05-31End: 2008-12-31Updated: 2012-11-28